These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18839776)

  • 81. Natural products for the management of the hepatitis C virus: a biochemical review.
    El-Tantawy WH; Temraz A
    Arch Physiol Biochem; 2020 May; 126(2):116-128. PubMed ID: 30269604
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Emerging antiviral drugs for hepatitis C virus.
    Enomoto M; Tamori A; Kawada N
    Rev Recent Clin Trials; 2009 Sep; 4(3):179-84. PubMed ID: 20028330
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Current and future therapy for chronic hepatitis C virus liver disease.
    Lake-Bakaar G
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):247-53. PubMed ID: 14529357
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Current and evolving therapies for hepatitis C.
    Moradpour D; Blum HE
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Promising candidates for the treatment of chronic hepatitis C.
    Walker MP; Yao N; Hong Z
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1269-80. PubMed ID: 12882616
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
    Kim SM; Song IH
    Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV.
    Laufer NL; Rockstroh JK
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):157-64. PubMed ID: 24350778
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Emerging therapeutic targets for hepatitis C virus infection.
    Jesudian AB; de Jong YP; Jacobson IM
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):612-9.e1. PubMed ID: 23583900
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Chronic hepatitis C : Standard treatment and remaining challenges].
    Zeuzem S
    Internist (Berl); 2018 Jun; 59(6):528-535. PubMed ID: 29696303
    [TBL] [Abstract][Full Text] [Related]  

  • 90. New drugs for hepatitis C virus (HCV).
    Clarke BE
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):293-305. PubMed ID: 10890323
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Chronic hepatitis and occult HCV infection].
    Kowala-Piaskowska A; Mozer-Lisewska I; Pham TN; Michalak TI
    Postepy Biochem; 2010; 56(4):383-8. PubMed ID: 21473042
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Overview of interferon therapy for chronic hepatitis C.
    Ahmed A; Keeffe EB
    Clin Liver Dis; 1999 Nov; 3(4):757-73. PubMed ID: 11291249
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [The molecular biology of hepatitis C virus].
    Koutsoudakis G; Forns X; Pérez-Del-Pulgar S
    Gastroenterol Hepatol; 2013 Apr; 36(4):280-93. PubMed ID: 23490024
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Second generation direct antivirals and the way to interferon-free regimens in chronic HCV.
    Lewis H; Cunningham M; Foster G
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):471-85. PubMed ID: 23199506
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HCV replication and statin pleotropism: an adjuvant treatment panacea?
    Torres DM; Harrison SA
    Am J Gastroenterol; 2008 Jun; 103(6):1390-2. PubMed ID: 18479495
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HCV drug discovery aimed at viral eradication.
    Schinazi RF; Bassit L; Gavegnano C
    J Viral Hepat; 2010 Feb; 17(2):77-90. PubMed ID: 20040045
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Modulation of host metabolism as a target of new antivirals.
    Ikeda M; Kato N
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1277-89. PubMed ID: 17897752
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection.
    Venugopal V; Padmanabhan P; Raja R; Dixit NM
    PLoS Comput Biol; 2018 Jul; 14(7):e1006335. PubMed ID: 30001324
    [TBL] [Abstract][Full Text] [Related]  

  • 99. New therapies on the horizon for hepatitis C.
    Sookoian SC
    Ann Hepatol; 2003; 2(4):164-70. PubMed ID: 15115955
    [TBL] [Abstract][Full Text] [Related]  

  • 100. New and experimental therapies for HCV.
    Pereira AA; Jacobson IM
    Nat Rev Gastroenterol Hepatol; 2009 Jul; 6(7):403-11. PubMed ID: 19575025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.